Concepedia

Brian Johnson

BJ

Statistics

Publications

16

Citations

749

H-Index

13

Active since

1992

Affiliations

University of California San Diego(Current)

Max Planck Institute for Evolutionary Biology

International Research Associates (United States)

Brian Johnson is an author at University of California San Diego specializing in medical microbiology, infectious diseases, and medicine.

ORCID

Publications per year

1992–2023

16

Publications

16

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)

Daryl J. Hoban, Samuel K. Bouchillon, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 205 citations

, , +7

Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002

S. Bouchillon, Brian Johnson, D. Hoban et al. · International Journal of Antimicrobial Agents · 2004 · 141 citations

, , +17

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)

Samuel K. Bouchillon, Daryl J. Hoban, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 88 citations

, , +7

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002

Samuel K. Bouchillon, Daryl J. Hoban, Brian Johnson et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 56 citations

, , +5

Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Clinical Isolates in the United States, 2004 to 2010

Benjamin A. Miko, Cory Hafer, Caroline J. Lee et al. · Journal of Clinical Microbiology · 2013 · 51 citations · Full text

, , +17

1–5 of 16